Related references
Note: Only part of the references are listed.Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus-infected patients from childhood to adulthood
Jia-Feng Wu et al.
HEPATOLOGY (2016)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients
Kyu Sik Jung et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance
P. P. Gounder et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant
William S. Mason et al.
GASTROENTEROLOGY (2016)
Hepatitis B Virus-Specific and Global T-Cell Dysfunction in Chronic Hepatitis B
Jang-June Park et al.
GASTROENTEROLOGY (2016)
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alpha-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin et al.
GASTROENTEROLOGY (2016)
Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression
Jessica Liu et al.
HEPATOLOGY (2016)
Discontinuation of oral antivirals in chronic hepatitis B: A systematic review
George Papatheodoridis et al.
HEPATOLOGY (2016)
Noninvasive Tests for Fibrosis Predict 5-Year Mortality and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Jeong Han Kim et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B
Anna S. Lok et al.
JOURNAL OF HEPATOLOGY (2016)
DIFFERENTIAL REDUCTIONS IN VIRAL ANTIGENS EXPRESSED FROM CCCDNAVS INTEGRATED DNA IN TREATMENT NAIVE HBEAG POSITIVE AND NEGATIVE PATIENTS WITH CHRONIC HBV AFTER RNA INTERFERENCE THERAPY WITH ARC-520
M. -F. Yuen et al.
JOURNAL OF HEPATOLOGY (2016)
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
Antje Blank et al.
JOURNAL OF HEPATOLOGY (2016)
NVR 3-778, A FIRST-IN-CLASS HBVCORE INHIBITOR, ALONE AND IN COMBINATION WITH PEG-INTERFERON (PEGIFN), IN TREATMENT-NAIVE HBEAG-POSITIVE PATIENTS: EARLY REDUCTIONS IN HBV DNA AND HBEAG
M-F. Yuen et al.
JOURNAL OF HEPATOLOGY (2016)
Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound
Jie Wang et al.
JOURNAL OF HEPATOLOGY (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatitis B Virus Capsids Have Diverse Structural Responses to Small-Molecule Ligands Bound to the Heteroaryldihydropyrimidine Pocket
Balasubramanian Venkatakrishnan et al.
JOURNAL OF VIROLOGY (2016)
Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus
Abdullah Ely et al.
MOLECULAR THERAPY (2016)
Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA
Christoph Seeger et al.
MOLECULAR THERAPY (2016)
Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor
Adrien Decorsiere et al.
NATURE (2016)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. dbj Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg plus Chronic Hepatitis B Infection
Mamun Al-Mahtab et al.
PLOS ONE (2016)
Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B
Kyle E. Korolowicz et al.
PLOS ONE (2016)
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent
Robert G. Gish et al.
ANTIVIRAL RESEARCH (2015)
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
Seiichi Sato et al.
IMMUNITY (2015)
Preventing Hepatitis B Reactivation Due to Immunosuppressive Drug Treatments
Robert P. Perrillo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Edward J. Gane et al.
JOURNAL OF HEPATOLOGY (2015)
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
Gi-Ae Kim et al.
JOURNAL OF HEPATOLOGY (2015)
Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
Stephan Menne et al.
JOURNAL OF HEPATOLOGY (2015)
High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein
Klaus Klumpp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation
Philipp Tropberger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Trained immunity in newborn infants of HBV-infected mothers
Michelle Hong et al.
NATURE COMMUNICATIONS (2015)
Immune Response in Hepatitis B Virus Infection
Anthony Tan et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
STING Agonists Induce an Innate Antiviral Immune Response against Hepatitis B Virus
Fang Guo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The immune tolerant phase of chronic HBV infection: new perspectives on an old concept
Antonio Bertoletti et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Serum Hepatitis B Virus RNA Levels as an Early Predictor of Hepatitis B Envelope Antigen Seroconversion During Treatment With Polymerase Inhibitors
Florian van Boemmel et al.
HEPATOLOGY (2015)
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
Huei-Ru Cheng et al.
HEPATOLOGY INTERNATIONAL (2015)
Management of Hepatitis B: Our Practice and How It Relates to the Guidelines
Suna Yapali et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
Stephan Urban et al.
GASTROENTEROLOGY (2014)
Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA
Henry L. Y. Chan et al.
GASTROENTEROLOGY (2014)
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Gi-Ae Kim et al.
GUT (2014)
Analysis of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA and Serum Viral Markers in Treatment-Naive Patients with Acute and Chronic HBV Infection
Weijie Li et al.
PLOS ONE (2014)
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Julie Lucifora et al.
SCIENCE (2014)
Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study
Anuj Gaggar et al.
VACCINE (2014)
Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection
Jia Liu et al.
PLOS PATHOGENS (2014)
Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus
V. de Ledinghen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
BASIC AND TRANSLATIONAL-LIVER
Robert E. Lanford et al.
GASTROENTEROLOGY (2013)
Prediction models of long-term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles
Mei-Hsuan Lee et al.
HEPATOLOGY (2013)
Reduction of Hepatitis B Surface Antigen Levels and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients Receiving 10 Years of Nucleoside Analogue Therapy
Wai-Kay Seto et al.
HEPATOLOGY (2013)
Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy
Ching-Lung Lai et al.
HEPATOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Alpha-Interferon Suppresses Hepadnavirus Transcription by Altering Epigenetic Modification of cccDNA Minichromosomes
Fei Liu et al.
PLOS PATHOGENS (2013)
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
Tai-Chung Tseng et al.
GASTROENTEROLOGY (2012)
Preserved T-Cell Function in Children and Young Adults With Immune-Tolerant Chronic Hepatitis B
Patrick T. F. Kennedy et al.
GASTROENTEROLOGY (2012)
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues
Carolina Boni et al.
GASTROENTEROLOGY (2012)
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
Antonio Bertoletti et al.
GUT (2012)
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
Laura Belloni et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Prediction of Liver-Related Events Using Fibroscan in Chronic Hepatitis B Patients Showing Advanced Liver Fibrosis
Seung Up Kim et al.
PLOS ONE (2012)
PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model
Horng-Tay Tzeng et al.
PLOS ONE (2012)
Risk Assessment of Hepatitis B Virus-Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan)
Kyu Sik Jung et al.
HEPATOLOGY (2011)
Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B
Emanuel K. Manesis et al.
JOURNAL OF HEPATOLOGY (2011)
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai-I Yang et al.
LANCET ONCOLOGY (2011)
Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
Paola Fisicaro et al.
GASTROENTEROLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Titers: Disease Phase Influences Correlation with Viral Load and Intrahepatic Hepatitis B Virus Markers
Alexander J. V. Thompson et al.
HEPATOLOGY (2010)
Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection
Hwai-I Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prospective Risk Assessment for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis C by Transient Elastography
Ryota Masuzaki et al.
HEPATOLOGY (2009)
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
Man-Fung Yuen et al.
JOURNAL OF HEPATOLOGY (2009)
Correlation Between Serum Hepatitis B Virus Core-Related Antigen and Intrahepatic Covalently Closed Circular DNA in Chronic Hepatitis B Patients
Fumitaka Suzuki et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
HBsAg seroclearance in chronic hepatitis B in Asian patients: Replicative level and risk of hepatocellular carcinoma
Man-Fung Yuen et al.
GASTROENTEROLOGY (2008)
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2008)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection
MK Maini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
